Drug intelligence / Profile preview

E45 complete emollient therapy

Development stage
Unknown
Lead developer
Karo Healthcare
Modality
Small Molecules
Administration
Topical
01

Overview

E45 Complete Emollient Therapy is a topical skincare regimen developed by Reckitt Benckiser Healthcare International for the management of dry skin conditions and mild to moderate atopic dermatitis (eczema). The regimen encompasses a combination of products, including soap-substitute washes and leave-on moisturizers like the core E45 Cream and E45 Itch Relief Cream. Its primary mechanism of action is the restoration and maintenance of the skin's natural barrier through the use of occlusive and emollient ingredients such as white soft paraffin, light liquid paraffin, and anhydrous lanolin. These components form a protective layer on the skin surface, significantly reducing transepidermal water loss (TEWL) and shielding the skin from external irritants. The therapy has been evaluated in Phase 4 clinical studies in the UK to assess its efficacy, safety, and impact on patient quality of life compared to standard emollient routines.

Brand names
E45E-45E 45E45 complete emollient therapyE-45 complete emollient therapyE 45 complete emollient therapyE45 Itch Relief CreamE-45 Itch Relief CreamE 45 Itch Relief CreamE45 CreamE-45 CreamE 45 Cream
Other names
E45 regimenE-45 regimenE 45 regimen

Beyond the preview

Go deeper on E45 complete emollient therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E45 complete emollient therapy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call